Diabetic fetal macrosomia: Significance of disproportionate growth*
References (32)
- et al.
Infants of diabetic mothers with accelerated fetal growth by ultrasonography: are they all alike
Am J Obstet Gynecol
(1990) - et al.
Clinical experience with a screening program for gestational diabetes
Am J Obstet Gynecol
(1983) - et al.
A simplified score for the assessment of fetal maturation of newly born infants
J Pediatr
(1979) - et al.
Glycosylated hemoglobin concentration in early gestation associated with neonatal outcome
Am J Obstet Gynecol
(1985) - et al.
Macrosomia despite a wellcontrolled diabetic pregnancy [Letter]
Lancet
(1983) - et al.
Pulmonary excretion of carbon monoxide in the human infant as an index of bilirubin production: II. Infants of diabetic mothers
J Pediatr
(1979) - et al.
Pulmonary excretion of carbon monoxide as an index of bilirubin production: IIa. Evidence for possible delayed clearance of bilirubin in infants of diabetic mothers
J Pediatr
(1981) - et al.
Neonatal polycythemia and hyperviscosity
Pediatr Clin North Am
(1982) - et al.
The infant of the diabetic mother: correlation of increased C-peptide levels with macrosomia and hypoglycemia
N Engl J Med
(1979) The pregnant diabetic and her newborn
(1977)
Neonatal jaundice in infants of diabetic mothers
Acta Paediatr Scand Suppl
Hemoglobin A1 in hemolysates from healthy and insulin-dependent diabetic children, as determined with a temperature-controlled mini-column assay
Clin Chem
Intrauterine growth as estimated from liveborn birth weight data at 24 to 42 weeks of gestation
J Pediatr
Eine neue Formel fur Bestimmung der Korperfulle, Korr.-B1
Gesellschaft Anthrophologie
Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks
Pediatrics
Jaundice in the healthy newborn infant: a new approach to an old problem
Pediatrics
Cited by (73)
Maternal Diabetes
2023, Avery's Diseases of the NewbornDeterminants of the persistency of macrosomia and shoulder dystocia despite treatment of gestational diabetes mellitus
2020, HeliyonCitation Excerpt :By contrast, infants with a PI ≥ 97th percentile have asymmetric macrosomia associated with a higher fat mass, and cord blood insulin and leptin levels [31]. Indeed, as compared to symmetric macrosomia, asymmetric macrosomia has been associated with an increased risk of neonatal complications in infants born to women with diabetes in several studies [32, 33, 34]. Furthermore, in the Hyperglycemia and Adverse Pregnancy Outcomes study, 78% of the infants defined as macrosomic by the LGA criterion were born to women without GDM, according to IADPSG criteria [35].
Predictors of Large-for-Gestational-Age Birthweight Among Pregnant Women With Type 1 and Type 2 Diabetes: A Retrospective Cohort Study
2019, Canadian Journal of DiabetesCitation Excerpt :Whereas studies have indicated that 8% to 23% of women with type 2 diabetes (T2DM) give birth to LGA infants (3,4), the rate of LGA in studies of women with type 1 diabetes (T1DM) range from 18% to 52% (3,4), and was found to be as high as 63% in one study (5). LGA is associated with maternal complications, such as high rates of cesaerean section and neonatal complications, such as shoulder dystocia, hypoglycemia, birth injury, jaundice and respiratory distress (6‒8). Although the theory of maternal hyperglycemia and subsequent fetal hyperinsulinemia has long been thought to be the primary mechanism of fetal overgrowth in pregnancies affected by diabetes (9), as maternal glycemic control has generally improved in the past decade (10), a coinciding reduction in the rate of LGA infants has not been observed.
Pseudoacromegaly
2019, Frontiers in NeuroendocrinologyCitation Excerpt :The mechanism by which obesity influences growth is has not yet been elucidated (Fennoy, 2013; Martinelli et al., 2011). Maternal diabetes is the most common cause of large-for-gestational-age infants, defined as birth length or weight greater than the 90th centile for gestational age, with approximately 45% of infants from diabetic mothers preseting macrosomia at birth (Ballard et al., 1993). An infant from a diabetic mother is exposed to sustained maternal hyperglycemia in case of unrecognized or poorly-controlled maternal diabetes, which may result in beta-cell hyperplasia and hyperinsulinism leading to fetal macrosomia.
Maternal Diabetes
2018, Avery's Diseases of the Newborn: Tenth Edition
- *
Supported in part by National Institutes of Health grant HD-11725, Diabetes in Pregnancy, and by National Institutes of Health Clinical Research Center grant RR00068 and the Alcyon Computer System.